Yubo International BiotechYBGJ Gross Margin % is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Yubo International Biotech ranks better than 74.04% on this metric.
YBGJ's Gross Margin % is ranked better than 74.04% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs YBGJ: 66.67
Yubo International Biotech had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Yubo International Biotech (OTCPK:YBGJ) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Yubo International Biotech had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Yubo International Biotech Gross Margin % Related Terms
Yubo International Biotech Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YBGJ vs GCTK, ECIA, RSCF: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Yubo International Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yubo International Biotech Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yubo International Biotech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Yubo International Biotech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Yubo International Biotech (YBGJ) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Yubo International Biotech and its competitors. Over the past decade, Yubo International Biotech's Gross Margin % has ranged from 50.96 to 91.58. According to the industry distribution chart, Yubo International Biotech ranks #209 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 26%.
Is Yubo International Biotech's Gross Margin % too high?
Yubo International Biotech's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 50.96 to a high of 91.58. Based on the distribution chart, Yubo International Biotech ranks #209 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Yubo International Biotech's Gross Margin % compare to GCTK and ECIA?
According to the Medical Devices & Instruments industry distribution chart, Yubo International Biotech ranks #209 out of 805 companies for Gross Margin %. This puts Yubo International Biotech in the upper half of its industry. The industry median Gross Margin % is 52.03. Historically, Yubo International Biotech's own Gross Margin % has ranged from 50.96 to 91.58 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Yubo International Biotech and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yubo International Biotech's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yubo International Biotech stock overvalued right now?
Yubo International Biotech (YBGJ) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Yubo International Biotech (YBGJ), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yubo International Biotech Ltd is a technology company focused on the research, development, and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of certain health management services and the sale of nebulizers containing frozen tubes with medical fluid. The nebulizers are sold directly to consumers on its online e-commerce platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YBGJ has been successfully added to your 